July 8, 2014 — Humana Inc. announced earlier this year an expanded coverage policy for cardiac CT (computed tomography). Many of the new Humana indications have long been advocated for by the Society of Cardiovascular Computed Tomography (SCCT) and described in the model local coverage determination policy (LCD) developed by the organization.

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits — both inpatient and emergency — and lower the risk for atrial fibrillation, according to research by the University of California San Francisco (UCSF).

CardiAQ Valve Technologies (CardiAQ), a leader in the field of transcatheter mitral valve implantation (TMVI), announced that the European Patent Office Legal Division issued a temporary stay of further proceedings in Neovasc’s pending European patent application covering TMVI technology. 

Thoratec Corp. has acquired Apica Cardiovascular Ltd. for an upfront cash payment of $35 million and potential future clinical and sales milestones of up to $40 million. 

Vital Connect announced its HealthPatch MD biosensor has received U.S. Food and Drug Administration (FDA) clearance. The solution is capable of capturing clinical-grade biometric measurements and is the first FDA-cleared medical device that includes a fall detection feature.

Corindus Vascular Robotics has been named the recipient of the 2014 North American New Product Innovation Award in Interventional Cardiology, which was established by Frost & Sullivan to recognize visionary innovation and product excellence.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now